What You Should Know:
– Unlearn®, a leading AI company using digital twins to revolutionize clinical trials, announced today a $50M Series C funding round led by Altimeter Capital. This investment, bringing Unlearn’s total funding…
Continue Reading
What You Should Know: ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally following the results of a year-long, successful effort launching trials in Asia Pacific.The collaboration will enable…
Continue Reading
Myoung Cha, Chief Product Officer at Verily
What You Should Know:
– Verily, an Alphabet precision health technology company appoints Myoung Cha as Chief Product Officer.
– As Chief Product Officer at Verily, Cha will lead strategy…
Continue Reading
What You Should Know:
– H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.
– The conversational AI tool empowers pharmaceutical…
Continue Reading
Gary Frazier, Chief Growth Officer at Helio Genomics
What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s…
Continue Reading
What You Should Know:
– Inovalon, a provider of cloud-based healthcare data analytics solutions, announced today the acquisition of VigiLanz, a prominent provider of SaaS-based clinical surveillance and patient safety software.
– This acquisition signifies Inovalon’s…
Continue Reading
Mike Szczesny, Owner & VP of EDCO Awards & Specialties
Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. On the one hand, leveraging individual patients’ personal experiences…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
What You Should Know: – PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. – The expansion doubles the platform’s reach,…
Continue Reading
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by…
Continue Reading
